1.
On the Application of Electronic Business in Medical Enterprises;
浅谈中国医药企业电子商务的应用及启示
2.
Impact of WTO Free-Trade Tariff Agreement on Chinese Pharmaceutical Firms
关税降低对于中国医药企业的影响及引申意义
3.
Development Strategies for Small and Medium-size Pharmaceutical Commercial Enterprises;
浅析我国中小型医药商业企业发展战略
4.
The Study of the Sustainable Growth Strategy of Small and Medium-size Pharmaceutical Enterprises in Our Country;
我国中小型医药企业持续发展战略研究
5.
The Influence of Traditional Family Ethical Culture on Family Drug Business;
传统家族伦理文化对中国家族医药企业的影响
6.
Considering on Strategy of Medical Distribution Enterprise s Network Marketing;
中国医药流通企业网络营销策略的思考
7.
Application of E-commerce Business Model in the National Pharmaceutical Enterprises;
电子商务模式在我国医药企业中的应用
8.
Using the game theory to analyze the small and medium-sized pharmaceutical enterprise’s optimal choice between innovation and imitation in China;
我国中小医药企业的创新与仿制的博弈分析
9.
Encouraging Policy of Governmentin Technical Innovation of Pharmaceutical Enterprises in Our Country;
论我国政府在医药企业技术创新中的激励政策
10.
A Research on Financial Distress Prediction in China's Pharmaceutical Companies Based on SVM
基于SVM的中国医药制造企业财务危机预警研究
11.
Talking about GAP Plant of Chinese Medicine and Development of Medical Enterprise;
浅谈中药材GAP种植与医药企业的发展
12.
The Present Situation and Promoting Strategies of Informationlization of Pharmaceutical Enterprises in Our Country;
我国医药企业信息化现状与推进策略
13.
Discussion on Logistics Management of China s Pharmacy Chains;
我国医药零售连锁企业物流管理研究
14.
Development Strategies on Competitive Intelligence in Chinese Pharmaceutical Enterprises;
我国医药企业竞争情报发展策略浅析
15.
On the Countermeasures of the Development of Chinese Medicine Enterprises after China s Entering WTO;
加入WTO与我国医药企业发展对策研究
16.
The Research of Channel Relationship Management in Our Pharmaceutical Manufacturer
我国医药生产企业渠道关系管理研究
17.
The Analysis of the Relationship between the Social Responsibility and the Achievements of the Chinese Medical Enterprises;
我国医药企业社会责任与企业绩效关系探析
18.
Research for New Medical and Health System Reform and Medicine Industry New Challenges in China
“新医改”条件下中国医药产业发展前瞻